MM&M Awards 2014: The Final Cut

More than 100 esteemed industry leaders and thinkers spent several hours discussing, reviewing and scoring around 700 entries to the MM&M Awards. Here are the results of their efforts—the 2014 finalists

MM&M Awards 2014: The Final Cut
MM&M Awards 2014: The Final Cut

Following two exhaustive rounds of scoring by 100 or so independent industry judges, the results are in for the MM&M Awards 2014. The finalists for each category are revealed on the following pages—but you'll have to wait for the spectacular dinner and ceremony at Cipriani 42nd Street  on October 2 to find out who will take home the gold and silver awards.

The MM&M Awards are judged with the utmost independence and authority, using an esteemed panel of leaders and thinkers representing a wide variety of disciplines and backgrounds within the healthcare marketing community. This year, we again incorporated a preliminary round of online reviews into the judging process. We also expanded the size of the panel to increase the number of judges reviewing each submission, allow more flexibility in matching judges' expertise with category disciplines, and enable an extended review of the leading contenders in the final round. 

Make no mistake. Judging the MM&M Awards is a serious business. It's not enough for a submission simply to look good—it must also be effective. That's why, in addition to seasoned creatives, we recruited more than 30 marketing and branding execs from the pharma industry to extend the authority and credibility of the judging process. We would like to thank all of our judges for their efforts.

Not even the judges will know who the winners are until they are called to the stage; the elation of claiming gold in front of hundreds of peers is second to none. Not to mention the following celebration. We hope to see you there.

To see a complete list of the finalists in all 31 categories, plus further information about the MM&M Awards, including dinner tickets, sponsorship opportunities, key dates and past winners, please visit our dedicated Awards website at

You must be a registered member of MMM to post a comment.

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.